Countable Labs launches revolutionary ten-color PCR platform, bridging the gap between PCR and next-generation sequencing ...
Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...
News-Medical.Net on MSN
Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, and Gencurix, Inc., a ...
Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics, today announced the appointment of Professor Dr. Carl Wittwer (picture), a global authority in PCR ...
PCR as a technique used daily in molecular biology / Jean-Paul Charlieu -- Design of primers for PCR / Andrew D. Sharrocks -- Purification of PCR products / Louis M. Mezei, Douglas R. Storts -- ...
DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. PCR is a powerful molecular biology ...
(Nanowerk News) PCR technology is a molecular diagnostics technology that detects target nucleic acids by amplifying the DNA amount. It has brought marked progress in the life sciences field since its ...
We will discuss the Digital LightCycler System, a digital PCR (dPCR) system for DNA and RNA with 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivity, ...
A new discovery has reshaped our understanding of PCR chip technology: water vapor, not air expansion, is the primary culprit behind bubble formation in polydimethylsiloxane (PDMS)-based chips. This ...
Molecular biologists have always faced the challenge of working with the smallest of specimens, expending a great deal of time and energy attempting to manipulate substances millions of times smaller ...
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results